Earlier today, the FDA approved esketamine (brand name Spravato), a chemical twin of the dissociative psychedelic/anaesthetic ketamine (Special K), as a treatment for depression. Spravato comes in nasal spray form meant to be administered weekly or every other week depending on the severity of the patient's depression.
"There has been a longstanding need for additional effective treatments for treatment-resistant depression, a serious and life-threatening condition," said the FDA's acting director of the Division of Psychiatry Products, Dr. Tiffany Farchione, in a press release. "Because of [safety] concerns, the drug will only be available through a restricted distribution system and it must be administered in a certified medical office where the health care provider can monitor the patient."
From National Public Radio:
Many doctors who have become comfortable offering ketamine for depression probably won't switch to esketamine, said Dr. Demitri Papolos, director of research for the Juvenile Bipolar Research Foundation and a clinical associate professor at Albert Einstein College of Medicine.
For the past 10 years, Papolos has been prescribing an intranasal form of ketamine for children and adolescents who have a disorder that includes symptoms of depression.
"I'm very pleased that finally the FDA has approved a form of ketamine for treatment-resistant mood disorders," Papolos said. He said the approval legitimizes the approach he and other doctors have been taking.
But he hopes that doctors who are currently using ketamine continue to do so. "It'll be a lot less expensive and a lot easier for their patients [than esketamine]," he said.
And animal studies show it's possible that old-fashioned ketamine is a more potent antidepressant than esketamine, Papolos said.
Esketamine "may not be as effective as a generic that any psychiatrist or physician can prescribe without restrictions," Papolos said.
Previously on Boing Boing:
• Dissociative psychedelic Ketamine may help suicidal children
• Report: Ketamine aids the chronically depressed
• Ketamine helps depressed patients temporarily experience pleasure again
Joint pain. Poor digestion. Hair loss. Erectile dysfunction. No libido. These are just a few of the lasting symptoms experienced by Kim Dong-hyeon, a bodybuilder in South Korea, after using over $3,000 of black-market steroids per month for many years. In this video he tells an Asian Boss reporter that he injected himself with steroids […]
More than 2,500 years ago in western China, people in mourning gathered at a cemetery for a ritual that involved getting high from cannabis plants burning in wooden pots. It’s likely that they were trying to communicate with spirits. From Science News: Evidence of this practice comes from Jirzankal Cemetery in Central Asia’s Pamir Mountains, […]
Oakland, California is now the second city in the United States, following Denver last month, to decriminalize psilocybin mushrooms. Oakland City Council unanimously passed the resolution on Tuesday. From NPR: Oakland’s resolution is broader than Denver’s. Denver’s initiative decriminalized the use and possession of mushrooms containing the compound psilocybin, whereas Oakland’s refers to “entheogenic plants” […]
So you cut the cord and got rid of cable? Join the steadily growing club. But while you’re out picking a streaming service, you might find one big blind spot: Local TV and sports, not to mention first-run programming from the big cable networks. Luckily, there’s a throwback way to get it for free: The […]
Even if you feel like AirPods are worth the price tag, you’ve got to admit there’s a certain anxiety that comes with using them. What if I lose them? What if they get wet in the rain? Or drenched in sweat? Or fall into the drink you dropped them into? Shiny tech is great, but […]
With the quick-fix appeal of video games and their own cell phones, it can be tough to keep kids focused on supposedly “educational” toys. And while it may seem counter-intuitive to fight tech with more tech, we’re all in when it comes to the Toybox 3D Printer. We’re not sure if anyone had envisioned a […]